Altogether, these results suggest that PAI1 is upregulated in rectal tumors and may be associated with reduced DFS, and that PAI1 could determine the response to treatment in rectal cancer, at least for the HUVR cohort. This evidence concerns the gene SERPINE1 and rectal cancer.